Literature DB >> 10075702

Heparin-induced conformational change in microtubule-associated protein Tau as detected by chemical cross-linking and phosphopeptide mapping.

H K Paudel1, W Li.   

Abstract

In Alzheimer's disease, microtubule-associated protein tau becomes abnormally phosphorylated and aggregates into paired helical filaments. Sulfated glycosaminoglycans such as heparin and heparan sulfate were shown to accumulate in pretangle neurons, stimulate in vitro tau phosphorylation, and cause tau aggregation into paired helical filament-like filaments. The sulfated glycosaminoglycan-tau interaction was suggested to be the central event in the development of neuropathology in Alzheimer's disease brain (Goedert, M., Jakes, R., Spillantini, M. G., Hasegawa, M., Smith, M. J., and Crowther, R. A. (1996) Nature 383, 550-553). The biochemical mechanism by which sulfated glycosaminoglycans stimulate tau phosphorylation and cause tau aggregation remains unclear. In this study, disuccinimidyl suberate (DSS), a bifunctional chemical cross-linker, cross-linked tau dimers, tetramers, high molecular size aggregates, and two tau species of sizes 72 and 83 kDa in the presence of heparin. In the absence of heparin only dimeric tau was cross-linked by DSS. Fast protein liquid chromatography gel filtration revealed that 72- and 83-kDa species were formed by intramolecular cross-linking of tau by DSS. These observations indicate that heparin, in addition to causing aggregation, also induces a conformational change in tau in which reactive groups are unmasked or move closer leading to the DSS cross-linking of 72- and 83-kDa species. Heparin-induced structural changes in tau molecule depended on time of heparin exposure. Dimerization and tetramerization peaked at 48 h, whereas conformational change was completed within 30 min of heparin exposure. Heparin exposure beyond 48 h caused an abrupt aggregation of tau into high molecular size species. Heparin stimulated tau phosphorylation by neuronal cdc2-like kinase (NCLK) and cAMP-dependent protein kinase. Phosphopeptide mapping and phosphopeptide sequencing revealed that tau is phosphorylated by NCLK on Thr212 and Thr231 and by cAMP-dependent protein kinase on Ser262 only in the presence of heparin. Heparin stimulation of tau phosphorylation by NCLK showed dependence on time of heparin exposure and correlated with the heparin-induced conformational change of tau. Our data suggest that heparin-induced conformational change exposes new sites for phosphorylation within tau molecule.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10075702     DOI: 10.1074/jbc.274.12.8029

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

1.  Understanding the kinetic roles of the inducer heparin and of rod-like protofibrils during amyloid fibril formation by Tau protein.

Authors:  Gayathri Ramachandran; Jayant B Udgaonkar
Journal:  J Biol Chem       Date:  2011-09-19       Impact factor: 5.157

2.  Regulation of cytoplasmic dynein ATPase by Lis1.

Authors:  Mariano T Mesngon; Cataldo Tarricone; Sachin Hebbar; Aimee M Guillotte; E William Schmitt; Lorene Lanier; Andrea Musacchio; Stephen J King; Deanna S Smith
Journal:  J Neurosci       Date:  2006-02-15       Impact factor: 6.167

3.  Functional anthology of intrinsic disorder. 3. Ligands, post-translational modifications, and diseases associated with intrinsically disordered proteins.

Authors:  Hongbo Xie; Slobodan Vucetic; Lilia M Iakoucheva; Christopher J Oldfield; A Keith Dunker; Zoran Obradovic; Vladimir N Uversky
Journal:  J Proteome Res       Date:  2007-03-29       Impact factor: 4.466

4.  Quantitative characterization of heparin binding to Tau protein: implication for inducer-mediated Tau filament formation.

Authors:  Hai-Li Zhu; Cristina Fernández; Jun-Bao Fan; Frank Shewmaker; Jie Chen; Allen P Minton; Yi Liang
Journal:  J Biol Chem       Date:  2009-12-03       Impact factor: 5.157

5.  HS3ST2 expression is critical for the abnormal phosphorylation of tau in Alzheimer's disease-related tau pathology.

Authors:  Julia Elisa Sepulveda-Diaz; Seyedeh Maryam Alavi Naini; Minh Bao Huynh; Mohand Ouidir Ouidja; Constantin Yanicostas; Sandrine Chantepie; Joao Villares; Foudil Lamari; Estelle Jospin; Toin H van Kuppevelt; Ayikoe Guy Mensah-Nyagan; Rita Raisman-Vozari; Nadia Soussi-Yanicostas; Dulce Papy-Garcia
Journal:  Brain       Date:  2015-04-04       Impact factor: 13.501

6.  Formation, release, and internalization of stable tau oligomers in cells.

Authors:  Susanne Wegmann; Samantha Nicholls; Shuko Takeda; Zhanyun Fan; Bradley T Hyman
Journal:  J Neurochem       Date:  2016-11-10       Impact factor: 5.372

7.  Remodeling of the conformational ensemble of the repeat domain of tau by an aggregation enhancer.

Authors:  Elias Akoury; Marco D Mukrasch; Jacek Biernat; Katharina Tepper; Valery Ozenne; Eckhard Mandelkow; Martin Blackledge; Markus Zweckstetter
Journal:  Protein Sci       Date:  2016-03-24       Impact factor: 6.725

Review 8.  It's all about tau.

Authors:  Cheril Tapia-Rojas; Fabian Cabezas-Opazo; Carol A Deaton; Erick H Vergara; Gail V W Johnson; Rodrigo A Quintanilla
Journal:  Prog Neurobiol       Date:  2018-12-31       Impact factor: 11.685

9.  Hepatoma-derived growth factor-related protein-3 interacts with microtubules and promotes neurite outgrowth in mouse cortical neurons.

Authors:  Heba M El-Tahir; Mekky M Abouzied; Rainer Gallitzendoerfer; Volkmar Gieselmann; Sebastian Franken
Journal:  J Biol Chem       Date:  2009-02-23       Impact factor: 5.157

10.  The principal neuronal gD-type 3-O-sulfotransferases and their products in central and peripheral nervous system tissues.

Authors:  Roger Lawrence; Tomio Yabe; Sassan Hajmohammadi; John Rhodes; Melissa McNeely; Jian Liu; Edward D Lamperti; Paul A Toselli; Miroslaw Lech; Patricia G Spear; Robert D Rosenberg; Nicholas W Shworak
Journal:  Matrix Biol       Date:  2007-03-30       Impact factor: 11.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.